Insider Transactions in Q3 2024 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 16
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
1,454
-3.09%
|
$63,976
$44.19 P/Share
|
|
Sep 16
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
4,665
-1.73%
|
$205,260
$44.19 P/Share
|
|
Sep 16
2024
|
Margaret A Horn Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,331
-3.17%
|
$190,564
$44.19 P/Share
|
|
Sep 16
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
11,715
-3.76%
|
$515,460
$44.19 P/Share
|
|
Sep 16
2024
|
Jack Anders Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,244
-2.22%
|
$98,736
$44.19 P/Share
|
|
Sep 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-2.96%
|
$716,681
$43.2 P/Share
|
|
Sep 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Aug 21
2024
|
Barbara Weber |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,808
-9.01%
|
$79,552
$44.83 P/Share
|
|
Aug 13
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-5.83%
|
$700,014
$42.98 P/Share
|
|
Aug 13
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Aug 05
2024
|
Frank Clyburn |
BUY
Grant, award, or other acquisition
|
Direct |
6,932
+50.0%
|
-
|
|
Aug 01
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
10,000
-1.56%
|
$460,000
$46.04 P/Share
|
|
Aug 01
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+3.01%
|
$40,000
$4.09 P/Share
|
|
Jul 15
2024
|
Stephen Michael Kelsey |
SELL
Open market or private sale
|
Direct |
16,667
-1.19%
|
$766,682
$46.02 P/Share
|
|
Jul 15
2024
|
Stephen Michael Kelsey |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+5.51%
|
$66,668
$4.09 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Indirect |
10,000
-16.43%
|
$450,000
$45.01 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
SELL
Open market or private sale
|
Direct |
25,000
-7.42%
|
$1,125,000
$45.05 P/Share
|
|
Jul 12
2024
|
Mark A Goldsmith |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+6.91%
|
$100,000
$4.09 P/Share
|
|
Jul 09
2024
|
Sushil Patel |
SELL
Open market or private sale
|
Direct |
2,155
-9.75%
|
$94,820
$44.0 P/Share
|
|
Jul 09
2024
|
Sushil Patel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,155
+8.88%
|
$34,480
$16.8 P/Share
|
|
Jul 09
2024
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,399
-4.85%
|
$95,960
$40.83 P/Share
|